Related Experiment Video
Updated: Apr 17, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Enabling the curation of your pharmacogenetic study
E m McDonagh1, M Whirl-Carrillo, R B Altman
1Department of Genetics, Stanford University, Stanford, California, USA.
Authors should follow 10 rules for clear reporting to aid pharmacogenetic association curation. This ensures accurate data integration into knowledgebases like PharmGKB for clinical pharmacogenomics.
Area of Science:
- Pharmacogenomics
- Clinical Pharmacology
- Biomedical Informatics
Background:
- Pharmacogenomics is increasingly integrated into clinical practice.
- Manual curation of published pharmacogenetic associations is crucial for knowledgebases.
- Challenges exist in curating findings due to information gaps in original reports.
Purpose of the Study:
- To provide guidelines for authors reporting pharmacogenetic associations.
- To improve the accuracy and completeness of curated data.
- To facilitate the integration of research findings into the Pharmacogenomics Knowledgebase (PharmGKB).
Main Methods:
- Manual curation of pharmacogenetic associations from published literature.
- Evaluation of study findings for uniformity and unambiguity using standard terminologies.
- Development of 10 rules for authors to enhance data clarity and completeness.
Main Results:
- Lack of clarity or standards in reports hinders data curation.
- Adherence to the proposed rules can improve data capture.
- Standardized reporting ensures findings are uniform and unambiguous.
Conclusions:
- Clear and standardized reporting by authors is essential for effective pharmacogenetic data curation.
- The 10 rules aim to optimize the integration of pharmacogenetic findings into PharmGKB.
- Improved curation supports the advancement of clinical pharmacogenomics.
More Related Videos
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenetics of Drug Metabolism: Overview
Principles of Pharmacogenetics: Types of Genetic Variants
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes